Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• SaxenaRDwivediAErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspectiveMed Res Rev10252010 [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• PrenzelNFischerOMStreitSHartSUllrichAThe epidermal growth factor receptor family as a central element for cellular signal transduction and diversificationEndocr Relat Cancer200181113111350724
   PubMed Web of Science ®Google Scholar
• SchlessingerJCell signaling by receptor tyrosine kinasesCell2000103221122511057895
   PubMed Web of Science ®Google Scholar
• SainsburyJRFarndonJRNeedhamGKMalcolmAJHarrisALEpidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancerLancet198718547139814022884496
   PubMed Web of Science ®Google Scholar
• KlijnJGBernsPMSchmitzPIFoekensJAThe clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patientsEndocr Rev19921313171313356
   PubMed Web of Science ®Google Scholar
• ToveySMWittonCJBartlettJMStantonPDReevesJRCookeTGOutcome and human epidermal growth factor receptor (HER) 1–4, status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labellingBreast Cancer Res200463R24625115084248
   PubMed Web of Science ®Google Scholar
• FerreroJMRamaioliALargillierREpidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-upAnn Oncol200112684184611484962
   PubMed Web of Science ®Google Scholar
• TsutsuiSOhnoSMurakamiSHachitandaYOdaSPrognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancerBreast Cancer Res Treat2002711677511859875
   PubMed Web of Science ®Google Scholar
• FoleyJNickersonNKNamSEGFR signaling in breast cancer: Bad to the boneSemin Cell Dev Biol201021995196020813200
   PubMedGoogle Scholar
• AzzazyHMMansourMMKazmierczakSCFrom diagnostics to therapy: prospects of quantum dotsClin Biochem20074013–1491792717689518
   PubMed Web of Science ®Google Scholar
• SalataOApplications of nanoparticles in biology and medicineJ Nanobiotechnology200421315119954
   PubMedGoogle Scholar
• MedintzILMattoussiHClappARPotential clinical applications of quantum dotsInt J Nanomedicine20083215116718686776
   PubMed Web of Science ®Google Scholar
• ChenCPengJXiaHSQuantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancerBiomaterials200930152912291819251316
   PubMed Web of Science ®Google Scholar
• ChenCPengJXiaHQuantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneityNanotechnology20101995101
   Google Scholar
• ChenCXiaHSGongYPThe quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different five-year prognosisBiomaterials201031338818882520723971
   PubMed Web of Science ®Google Scholar
• DakoEGFR PharmDxTM Interpretation ManualAvailable from: http://www.dako.com/08052_egfr_pharmdx_interpretation_manual.pdfAccessed August 8, 2011.
   Google Scholar
• KotsakisAGeorgouliasVTargeting epidermal growth factor receptor in the treatment of non-small-cell lung cancerExpert Opin Pharmacother201011142363238920586711
   PubMed Web of Science ®Google Scholar
• PaoWChmieleckiJRational, biologically based treatment of EGFRmutant non-small-cell lung cancerNat Rev Cancer2010101176077420966921
   PubMed Web of Science ®Google Scholar
• LiSSchmitzKRJeffreyPDWiltziusJJKussiePFergusonKMStructural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell20057430131115837620
   PubMed Web of Science ®Google Scholar
• CrippsCWinquistEDevriesMCStys-NormanDGilbertREpidermal growth factor receptor targeted therapy in stages III and IV head and neck cancerCurr Oncol2010173374820567625
   PubMed Web of Science ®Google Scholar
• ChiuCWNozawaHHanahanDSurvival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesisJ Clin Oncol201028294425443320823411
   PubMed Web of Science ®Google Scholar
• LurjeGLenzHJEGFR signaling and drug discoveryOncology200977640041020130423
   PubMed Web of Science ®Google Scholar
• HigaGMSinghVAbrahamJBiological considerations and clinical applications of new HER2-targeted agentsExpert Rev Anticancer Ther20101091497150920836684
   PubMed Web of Science ®Google Scholar
• McIntyreEBlackburnEBrownPJJohnsonCGGullickWJThe complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancerBreast Cancer Res Treat2010122110511019760033
   PubMed Web of Science ®Google Scholar
• YonemoriKTsutaKShimizuCImmunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapyJ Surg Oncol2010101322222720087905
   PubMed Web of Science ®Google Scholar
• HendriksBSOrrGWellsAWileyHSLauffenburgerDAParsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cellsJ Biol Chem200528076157616915572377
   PubMed Web of Science ®Google Scholar
• GrossMEShazerRLAgusDBTargeting the HER-kinase axis in cancerSemin Oncol2004311 Suppl 392015052539
   PubMed Web of Science ®Google Scholar
• BaulidaJKrausMHAlimandiMDi FiorePPCarpenterGAll ErbB receptors other than the epidermal growth factor receptor are endocytosis impairedJ Biol Chem19962719525152578617810
   PubMed Web of Science ®Google Scholar
• TsutsuiSOhnoSMurakamiSKataokaAKinoshitaJHachitandaYPrognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancerSurgery2003133221922112605184
   PubMed Web of Science ®Google Scholar
• PengCWLiuXLChenCPatterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironmentBiomaterials201132112907291721262536
   PubMed Web of Science ®Google Scholar